Bernd Weigle
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- RNA Interference and Gene Delivery 6
- S100 Proteins and Annexins 4
- Cell death mechanisms and regulation 4
- Immunology 19
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 4
- Co-authors
- Marc Schmitz (23 shared papers)E. Peter Rieber (17 shared papers)Andrea Kießling (15 shared papers)Achim Temme (16 shared papers)Michael Bachmann (9 shared papers)Stefan Stevanović (7 shared papers)Ernst Peter Rieber (6 shared papers)Claus W. Heizmann (3 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (5 papers)Cancer Letters (4 papers)The Prostate (3 papers)The FASEB Journal (2 papers)International Journal of Oncology (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Bernd Weigle
45 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 106
- Clinical Biochemistry 565
- Immunology 787
- Sensory Systems 110
- Oncology 483
- Molecular Biology 1.1k
Countries citing papers authored by Bernd Weigle
This map shows the geographic impact of Bernd Weigle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Weigle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Weigle more than expected).
Fields of papers citing papers by Bernd Weigle
This network shows the impact of papers produced by Bernd Weigle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Weigle. The network helps show where Bernd Weigle may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernd Weigle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 209 | |
| 2 | Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides. | 2000 | 183 |
| 3 | 2007 | 173 | |
| 4 | Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. | 2000 | 144 |
| 5 | 2002 | 113 | |
| 6 | 2005 | 113 | |
| 7 | 2005 | 112 | |
| 8 | 2004 | 94 | |
| 9 | 2004 | 86 | |
| 10 | 2007 | 82 | |
| 11 | 2005 | 81 | |
| 12 | 2005 | 77 | |
| 13 | 2003 | 77 | |
| 14 | 2003 | 74 | |
| 15 | 2005 | 68 | |
| 16 | 2012 | 66 | |
| 17 | 2002 | 62 | |
| 18 | 2003 | 61 | |
| 19 | 2021 | 60 | |
| 20 | 2010 | 51 |
About Bernd Weigle
Bernd Weigle is a scholar working on Molecular Biology, Immunology, Clinical Biochemistry, Oncology and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 2.6k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (15 papers), Immunotherapy and Immune Responses (12 papers), RNA Interference and Gene Delivery (6 papers), S100 Proteins and Annexins (4 papers), Cell death mechanisms and regulation (4 papers), Immune Cell Function and Interaction (4 papers), CAR-T cell therapy research (4 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Clinical Biochemistry (565 citations), Immunology (787 citations), Sensory Systems (110 citations), Oncology (483 citations) and Molecular Biology (1.1k citations). Bernd Weigle has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Marc Schmitz, E. Peter Rieber, Andrea Kießling, Achim Temme, Michael Bachmann, Stefan Stevanović, Ernst Peter Rieber, Claus W. Heizmann, Michael A. Rieger and Jacques Rohayem. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cancer Letters, The Prostate, The FASEB Journal and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.